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Abstract
Experiences of profound existential or spiritual significance can be triggered 
reliably through psychopharmacological means using psychedelic substances. 
However, little is known about the benefits of religious, spiritual, or mystical 
experiences (RSMEs) prompted by psychedelic substances, as compared 
with those that occur through other means. In this study, 739 self-selected 
participants reported the psychological impact of their RSMEs and indicated 
whether they were induced by a psychedelic substance. Experiences induced 
by psychedelic substances were rated as more intensely mystical (d = .75, 
p < .001), resulted in a reduced fear of death (d = .21, p < .01), increased 
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sense of purpose (d = .18, p < .05), and increased spirituality (d = .28, p < 
.001) as compared with nonpsychedelically triggered RSMEs. These results 
remained significant in an expanded model controlling for gender, education, 
socioeconomic status, and religious affiliation. These findings lend support to 
the growing consensus that RSMEs induced with psychedelic substances are 
genuinely mystical and generally positive in outcome.
Keywords
mystical experience, religious experience, spiritual experience, psychedelic, 
spirituality, self-transcendent experience, religion
Introduction
“That men and women can, by physical and chemical means, transcend 
themselves in a genuinely spiritual way . . . seems rather shocking. But, after 
all, the drug or the physical exercise is not the cause of the spiritual experience; 
it is only its occasion.”
—Aldous Huxley
Psychoactive substances can inspire some of life’s most profound and mean-
ingful moments. Specifically, psychedelic substances reliably induce reli-
gious, spiritual, or mystical experiences (RSMEs; Beauregard, 2011), even in 
tightly controlled laboratory settings (Griffiths, Richards, McCann, & Jesse, 
2006; Turton, Nutt, & Carhart-Harris, 2014). Such experiences can also 
occur without the influence of psychoactive substances, through occasions 
such as near death experiences, religious rituals, practices like meditation, as 
well as spontaneously. People often report that such experiences are positive, 
spiritual, and, in some cases, transformative, irrespective of the particular 
trigger of the RSME.
In the Varieties of Religious Experience, William James (1902/1999) 
applies his “pragmatic principle,” which entails attending to the outcomes of 
such experiences, rather than questioning or dismissing them based on their 
origins. Arguing the same case, Stace (1960) refers to “causal indifference,” 
suggesting that so long as the proximate trigger of the mystical state is not 
part of the phenomenological description, the origin is beside the point. These 
authors put forward that the merit of a given experience ought to derive from 
its “fruits,” (outcomes) not its “roots” (origins; James, 1902/1999). Yet others 
argue that experiences that are induced pharmacologically are less genuine or 
beneficial than those that occur spontaneously or through other means 
(Zaehner, 1972). While this has been debated theoretically (Kellenberger, 
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1978; Smith, 1964; Zaehner, 1972), empirical studies are warranted that com-
pare spiritually significant experiences induced through psychopharmaco-
logical and nonpsychopharmacological means. The current study addresses 
this need.
The capability for psychoactive substances to exert profound psychologi-
cal effects is notable for a number of reasons. First, the phenomenological 
aspects of such experiences are relatively brief—usually only several min-
utes or hours—compared with the duration of the experience’s long-term per-
sonality and behavioral effects, which can persist for years or decades 
(Doblin, 1991; Forman, 1999; Griffiths, Richards, Johnson, McCann, & 
Jesse, 2008; MacLean, Johnson, & Griffiths, 2011). Second, such experi-
ences can be relatively easily induced in laboratory settings. Third, the expe-
rience is almost entirely subjective, with few changes in distinct bodily 
activity or behavior during the experiences—that is to say, all of these changes 
can occur during a few hours of lying on a couch. Fourth, such experiences 
are often interpreted in religious or spiritual terms, perhaps suggesting stable 
phenomenological qualities that cue religious and spiritual interpretations. 
Understanding the subjective qualities and content of such experiences, as 
well as the ways in which culture affects their interpretation, is thus a compli-
cated yet necessary aim for further scientific inquiry with significant clinical 
implications.
The broad class of psychoactive substances known as “psychedelics,” “hallu-
cinogens,” or “entheogens” (MacLean et al., 2011) encompasses many com-
pounds, including the more well-known substances of psilocybin (mushrooms), 
lysergic acid diethylamide(LSD), mescaline (peyote), and N,N-Dimethyltryptamine 
(DMT; also an active compound in ayahuasca). These substances generally work 
as serotonin receptor (5-HT2) agonists (Aghajanian & Marek, 1999; Ebersole, 
Visiers, Weinstein, & Sealfon, 2003; Nelson, Lucaites, Wainscott, & Glennon, 
1999; Scruggs, Patel, Bubser, & Deutch, 2000), although other hallucinogenic 
compounds (e.g., ketamine, phencyclidine) can affect different neurotransmitter 
systems (for a review, see Yaden, Iwry, & Newberg, 2016). Many psychedelics 
have very low toxicity (Jaffe, 1990; McGlothlin & Arnold, 1971; Nichols, 2004; 
O’Brien, 1996) and some have been used for thousands of years for religious or 
spiritual purposes. Religious rituals involving such substances have been observed 
in indigenous cultures in Africa, South America, and North America (Grob, 2002; 
Ruck, Bigwood, Staples, Ott, & Wasson, 1979). Allegro (1971) traces the history 
of psychoactive substances in monotheistic traditions; Hillman (2008) has identi-
fied rituals in ancient Greece that incorporated psychedelic substances.
Religious or spiritual interpretations are common to psychedelic experi-
ences. Reports of religious or spiritual imagery are common across a number 
of studies using psychedelic substances (Masters & Houston, 1966). In the 
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hallmark “Good Friday experiment,” subjects attending a Christian religious 
service at Marsh Chapel at Harvard University had more intensely religious 
and spiritual experiences after being administered psilocybin than did those 
administered an inert control substance (Pahnke, 1966). Notably, participants 
in the drug condition still found the experience meaningful decades later 
(Doblin, 1991). Unfortunately, the most compelling findings from research 
conducted during this era of scholarship were overshadowed by the percep-
tion of ethical violations, unrestrained enthusiasm by a few early researchers 
in the field, and a reactionary ban on psychedelic substances even for research 
purposes (Baumeister & Placidi, 1983).
More recent work has adhered to rigorous research and ethical standards, 
and contemporary studies continue to find reports of positive outcomes stem-
ming from psychedelic-induced experiences. For instance, when Griffiths 
et al. (2006) administered psilocybin to psychedelic-naive subjects, 67% 
reported that the experience was among the top five most meaningful experi-
ences of their lives—71% rated the experience in their top five most spiritual-
ity significant experiences. Most participants under the influence of psilocybin 
met the researcher’s criteria for a mystical experience—a member of the 
class of RSMEs that emphasizes feelings of unity, transcendence of time and 
space, noetic quality, and positive mood (Pahnke, 1966; Stace, 1960). 
Outcomes such as heightened mood, altruistic social effects, and other posi-
tive behavioral changes persisted at 2- and 18-month follow-ups (Griffiths 
et al., 2008).
Reviews of the extant literature on psychedelic research suggest a quali-
fied consensus that psilocybin can produce mystical experiences in a sup-
portive therapeutic milieu in controlled research settings (Ellens, 2014; Grob, 
2002; Grob et al., 2011; Turton et al., 2014). Legal restrictions on substance 
research are relaxing, indicating that the scientific and legal communities are 
coming to realize psychedelics’ potential value (Ellens & Roberts, 2015). The 
cumulative effect of psychedelic research has demonstrated that these sub-
stances can induce experiences of profound spiritual and existential meaning, 
leading to more specific questions about the similarities and differences 
between spiritual experiences, their subjective effects, and their overlapping 
relationships to the brain.
A question that has arisen in extensive theoretical debate is the extent to 
which experiences triggered by psychoactive substances such as psilocybin 
are as beneficial or meaningful as RSMEs that occur spontaneously or 
through other “natural” means (Kellenberger, 1978; Smith, 1964; Zaehner, 
1972). William James (1902/1999) argued that the emotions, transformation, 
and changed behaviors that are borne of an experience (the fruits) matter far 
more than what might have caused the experience (the roots). His argument 
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was in reference to experiences borne of blatantly physiological origins. He 
gave the example that some explain (or explain away) St. Paul’s epiphany on 
the Road to Damascus as merely an epileptic seizure. James wrote,
Medical materialism finishes up Saint Paul by calling his vision on the road to 
Damascus a discharging lesion of the occipital cortex, he being an epileptic. It 
snuffs out Saint Teresa as an hysteric, Saint Francis of Assisi as a hereditary 
degenerate. (p. 23)
Yet whether Paul’s epiphany was due to a seizure or a true encounter with 
God may be beside the point; the experience was transformative, and Paul 
turned from being a persecutor of Christians to an early church leader 
(Longenecker, 1997). James thus argues that the meaning and significance of 
a subjective experience cannot be deflated by an account of its physiological 
origin.
James’s argument is useful when examining RSMEs triggered by psyche-
delic substances. Along these lines, some scholars suggest that psychedeli-
cally induced RSMEs are essentially the same as spontaneous RSMEs, the 
latter of which are often assumed inherently mystical in nature (e.g., Hood, 
2014; Huxley, 1958; Smith, 1964). Yet other scholars hold that the origin of 
RSMEs differentiates them into distinct categories (Redmond, 2004). For 
example, Zaehner (1972) called RSMEs triggered by psychedelics “psyche-
delic mysticism,” claiming that such experiences cannot be equated with 
spontaneous or “genuine” mystical experiences. He argued that although psy-
chedelic experiences contain content related to nature and unity, they lack a 
sense of sacredness. Interestingly, he later revised this view after studies 
demonstrated the prevalence of sacredness in reports of psychedelic experi-
ences (Hood, Hill, & Spilka, 2009; Wulff, 1991; Zaehner, 1972).
The positive impact of psychedelic versus nonpsychedelic RSMEs is 
another point of contention. Smith et al. (2004) point out that the question of 
whether psychedelically induced RSMEs are as effective at beneficially 
altering behaviors and traits remains an open question—one that has been 
discussed at length in the extant psychedelic literature (Ellens, 2014).
The debate over the spiritual and positive impact of psychedelic experi-
ences has been primarily theoretical in nature. Empirical studies are war-
ranted to evaluate long-held theoretical propositions. In this study, we used 
questionnaire data from an online survey to compare psychedelically trig-
gered and nonpsychedelically triggered RSMEs. We hypothesized that there 
would be nonsignificant differences in psychedelic-occasioned RSMEs when 
compared with nonpsychedelic-occasioned RSMEs in (a) mystical quality 
(as measured by a measure of mystical experience); (b) positive impact in the 
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domains of family, reduced fear of death, health, and sense of purpose; and 
(c) sense of religiosity and spirituality. Each of these hypotheses focus on 
how the “roots,” or origins, influence the “fruits,” or outcomes, of RSMEs.
Method
Participants
Data came from 739 individuals (379 males, 335 female, 25 other/unknown), 
drawn from an existing data set of 839 respondents who completed an online 
survey about RSMEs. The online survey, hosted on a University of 
Pennsylvania website developed by the authors (ABN) and (NAW), indicated 
that it was intended to explore the nature of religious and spiritual experi-
ences. The University of Pennsylvania’s Institutional Review Board approved 
this study.
Sample characteristics can be found in Table 1. Survey participants were 
primarily White/Caucasian (82.8%) and middle class (76.2%). There was an 
unusually high number of atheists in this sample (25%), compared with the 
general population (1.6%; Pew Research Center, 2008). Of the total 839 
respondents, 100 individuals were excluded from the current analyses due to 
incomplete data on the measures of interest. Participants excluded due to 
incomplete data were less likely to be Atheists, χ2(1) = 4.23, p = .04, or other 
religions, χ2(1) = 4.50, p = .03, but were equally likely to be Christians, 
χ2(1) = .00, p = 1.00, as those included in the current analyses. There were 
more American Indians in the excluded sample, χ2(1) = 7.64, p = .01, but no 
differences for other ethnicities, White: χ2(1) = 1.09, Asian: χ2(1) = 0.00, 
Black: χ2(1) = 0.50, Hispanic: χ2(1) = 0.40; all ps > .05, gender, χ2(1) = 2.35, 
p = .13, socioeconomic status (SES), χ2(2) = 0.31, p = .86, educational attain-
ment, χ2(5) = 3.95, p = .56, or hallucinogenic use, χ2(1) = 0.00, p = .99. 
Included participants scored higher on the Mysticism Scale, 3.22 versus 3.03, 
t(837) = 3.28, p = .001, d = .20.
Measures
A subset of questions and scales from the larger survey were included in the 
current study.
Demographics. Participants reported their religious affiliation (Christian, 
Jewish, atheist, Eastern religions, other), level of education, SES (low, mid-
dle, upper), gender, and ethnicity (White, Black, Asian, Hispanic, other/
unknown).
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Mystical Experience. Mystical experiences were measured using the mystical 
experience subscale of the Death Transcendence Scale (Hood & Morris, 
1983). This five-item measure has four Likert-type response categories rang-
ing from strongly disagree to strongly agree. Sample items include “I have 
had an experience in which I felt everything in the world to be part of the 
same whole” and “I have had an experience in which I realized the oneness 
of myself with all things.” This subscale is based on Hood’s Mysticism Scale 
Table 1. Descriptive Statistics and Spearman Correlations (for Continuous/
Ordinal Variables) or Chi-Square (for Categorical Variables) With Psychedelic Drug 
Use.
Variable N Mean (%) SD Min Max ρ χ2
Psychedelic drug usea 739 0.47 0.50 0 1 1.00  
Mysticism 714 3.22 0.88 1 4 .35**  
RSME impact 690 4.12 0.59 1 5 .10**  
 Family 679 3.87 1.00 1 5 .05  
 Purpose 687 4.39 0.84 1 5 .09*  
 Spirituality 685 4.64 0.71 1 5 .14**  
 Religiousness 673 3.59 1.15 1 5 .02  
 Reduced fear of 
death
685 4.36 0.83 2 5 .10**  
 Health 683 3.83 0.88 1 5 .07  
Genderb 714 0.47 0.50 0 1 −.40**  
Education 739 2.87 1.17 1 5 −.35**  
SESc 720 1.98 0.47 1 3 −.19**  
Ethnicity 14.99**
 White 612 82.8%  
 Hispanic 25 3.4%  
 Black 17 2.3%  
 Asian 17 2.3%  
 Other/unknown 68 9.2%  
Religion 74.08**
 Christian 153 20.7%  
 Atheist 185 25%  
 Eastern religion 58 7.8%  
 Other/unknown 343 46.4%  
Note. RSME = religious, spiritual, mystical experience; SES = socioeconomic status. Differing 
Ns due to missing data on some measures. Spearman ρ correlations, due to the ordinal nature 
of most variables. RSME impact refers to composite across the six domains.
aDrug use: 0 = no, 1 = yes. bGender: 0 = male, 1 = female. cSES: 1 = low, 2 = middle, 3 = upper.
*p < .05. **p < .01.
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(1975), the most widely used measure for experiences involving spiritual or 
visceral feelings of unity (Hood et al., 2001; Lukoff & Lu, 1988). Internal 
consistency in the current sample was excellent (α = .90).
Psychedelic Experience. Two items were used to determine whether an experi-
ence was occasioned by a psychedelic substance: “Certain substances have 
been hypothesized to affect the human brain. Which of these substances have 
you ever taken?” and “Has it affected your spiritual or religious experience?” 
Participants also endorsed other nonpsychedelic RSME triggers, including 
diseases, trauma, ritual, near death experience, religious activity, spontane-
ous, meditation, and others, though these data are not included in these analy-
ses. To be included in the psychedelic-triggered RSME group, participants 
had to indicate that they had taken hallucinogens in the first question and had 
to answer in the affirmative that the substance had influenced their RSME.
RSME Impact. Six single-item questions measured how RSMEs influenced 
participants’ lives across the domains of family, reduced fear of death, health, 
sense of purpose, religiousness, and spirituality. Items were scored on a 
5-point scale, and were analyzed as separate outcomes, and were also aver-
aged together to indicate an overall RSME impact (α = .71).
Data Analysis
Spearman correlations and independent sample chi-square tests were used to 
compare the demographic characteristics of participants reporting a psyche-
delic experience with participants who indicated other triggers for their 
RSME. A series of analyses of covariance (ANCOVAs) were then conducted 
to compare mysticism experience and RSME impact across multiple domains, 
controlling for gender, SES, education, and religion.
Results
Of the 739 participants, 347 indicated that their RSME was psychedelically 
induced, and 392 indicated that the RSME was nonpsychedelically induced. 
Table 1 summarizes the demographic profile for each group and provides 
Spearman correlations or chi-square tests of independence between each 
variables and psychedelic drug use. The psychedelic group included more 
men (72.3% vs. 32.7%), fewer Christians (7.2% vs. 32.7%), and more “other” 
religions (54.2% vs. 39.5%). Psychedelic use was inversely related to educa-
tion and SES. Experiences induced by psychedelic substances were rated as 
more mystical (d = .75, p < .001), resulted in a reduced fear of death (d = .21, 
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p < .01), increased sense of purpose (d = .18, p < .05), and increased spiritual-
ity (d = .28, p < .001) as compared with nonpsychedelically triggered RSMEs.
ANCOVAs tested psychedelic drug use predicting mysticism and RSME 
impact, controlling for gender (0 = male, 1 = female), education and SES 
(ordinal variables), and religious affiliation (dummy coded as 1 = Christian, 
0 = other). As summarized in Table 2, participants with psychedelic-triggered 
RSMEs scored higher on mystical experience and overall RSME impact than 
those whose RSME had occurred through other means. Secondary analyses 
were also performed. Additional ANCOVAs revealed that after controlling 
for SES, gender, education, and religious affiliation, mystical experience was 
slightly linked to the influence of opiate, p < .01, F(1) = 14.08, ηp2 = .02, and 
party drug, p < .01, F(1) = 12.5, ηp2 = .02, but antidepressants, psychiatric 
medications, sedatives, and antianxiety medications were not linked with 
mystical experience (ps > .10).
Discussion
The current study empirically examined the demographic profiles and impact 
of RSMEs induced through pharmacological means (psychedelic substances) 
versus RSMEs that occurred through other means. Contrary to our hypotheses 
that we would find no difference between these groups, RSMEs that were 
Table 2. Analyses of Covariance Comparing Psychedelic and Nonpsychedelic 
RSMEs.
Outcome
Psychedelic 
group
Nonpsychedelic 
group
F p
Partial 
η2N M SD N M SD
Mysticism 333 3.54 0.65 351 2.92 0.96 63.56 <.001 .086
RSME impact 331 4.18 0.53 331 4.06 0.64 7.88 .005 .012
 Family 329 3.91 1.01 324 3.81 1.00 3.72 .054 .006
 Purpose 331 4.47 0.80 328 4.32 0.87 4.92 .027 .007
 Spirituality 329 4.74 0.59 329 4.56 0.80 16.44 <.001 .025
 Religiousness 327 3.65 1.16 318 3.58 1.13 0.73 .393 .001
 Reduced fear 
of death
331 4.44 0.79 326 0.426 0.87 6.03 .014 .009
 Health 330 3.89 0.83 325 3.78 0.91 1.10 .295 .002
Note. RSME = religious, mystical, and spiritual experience. Analyses control for gender, 
education, socioeconomic status, and religious affiliation (dummy coded variable, 1 = Christian, 
0 = other). Differing Ns due to missing data on some measures; RSME impact refers to 
composite across the six domains.
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induced with psychedelic substances were rated as (a) being significantly 
more mystical, (b) having greater positive or existential impact (in terms of 
decreased fear of death and increased sense of purpose), and (c) increasing 
participants’ spirituality more than did RSMEs triggered through other means.
The theoretical literature on RSMEs typically casts psychedelically 
induced experiences as artificial. Thus, such experiences are viewed as remi-
niscent of, but not equal to, the “real thing” (Walsh, 2003). Additionally, psy-
chedelically triggered experiences have often been assumed to be mere 
“flashes in the pan” with little possibility for long-term positive outcomes 
(Zaehner, 1972). Of course, many psychedelic experiences do not have reli-
gious or spiritual import. However, the data from this study cast doubt on the 
assumption that RSMEs induced through psychedelic substances are any less 
genuine, positive, or spiritually significant. On the contrary, our participants 
rated psychedelic-triggered RSMEs as more intensely mystical, more posi-
tive in impact, and more related to spiritual and existential outcomes.
The greatest difference between psychedelic and nonpsychedelic experi-
ences was in terms of mysticism, in this study, measured with a scale that 
emphasizes the degree of unity felt during the experience. It may be the case 
that mystical experiences occasioned by psychedelic substances are rated as 
more mystical because of the degree of visceral subjective and sensory 
changes that psychedelics reliably produce.
Psychedelic use has been associated with a variety of positive mood and 
behavioral outcomes, but it is essential to differentiate psychedelic substances 
from other drugs. Psychedelic use, unlike the use of other types of illicit sub-
stances, is associated with reduced psychological distress and suicidality 
(Hendricks, Thorne, Clark, Coombs, & Johnson, 2015). In their survey of 
over 190,000 U.S. respondents, Hendricks, Clark, Johnson, Fontaine, and 
Cropsey (2015) found that whereas lifetime use of other illicit drugs was 
largely associated with an increased likelihood of psychological distress and 
suicidality, lifetime psychedelic use was protective against these outcomes. 
Psychedelic use also predicts reduced recidivism among substance-involved 
offenders (Hendricks et al., 2014). Perhaps due to activity in the serotonergic 
system, psychedelics may also have antidepressant effects (Vollenweider & 
Kometer, 2010) and may be useful in the treatment of clinical depression 
(Anderson, 2012).
The finding that psychedelic-induced experiences were rated as more spir-
itual than nonpsychedelic experiences was particularly surprising as psyche-
delic substances represent an obviously physical, rather than supernatural, 
causal trigger of the experience. However, as previous work on the topic has 
discussed at length, the psychedelic substance is often not considered the 
“cause” but rather the “occasion” of the experience (Griffiths et al., 2006; 
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Hood, 2014; Huxley, 1958; Smith, 1964). That is, psychedelic substances 
may provide a potent context for a genuinely spiritual experience, leading to 
enhanced feelings of spirituality.
Responsible use, proper regulations, and a supportive or therapeutic 
milieu (including a safe and appropriate setting as well as well-informed 
expectations and mind-set) are essential caveats to any discussion of psyche-
delic substances. The current findings, which suggest that unsupervised psy-
chedelic use can result in RSMEs with positive outcomes, are consistent with 
a growing body of data from laboratory settings (Griffiths et al., 2008; Grob 
et al., 2011). However, our findings address only positive subjective feelings 
and experiences stemming from psychedelic use; therefore, conclusions 
regarding benefits or risks associated with other outcomes, such as physical 
health or psychological distress, cannot be drawn.
Limitations
The present study was limited in several ways. The sample was not represen-
tative of the population at large. There were an unusually high number of 
atheists in this sample and fewer Christians compared with the U.S. popula-
tion. The online survey was hosted on a website that made clear that the sur-
vey sought to measure RSMEs. Therefore, there was likely a self-selection 
bias in favor of those who were already familiar with such experiences. Our 
findings should be examined in a population-level sample, and replicated 
through more covert means, such as being part of a larger survey.
All measures were self-reported in this cross-sectional correlational study. 
We cannot determine, for example, if those who used psychedelic substances 
had a higher tendency to experience mystical-type states. Interventional and 
prospective longitudinal studies are warranted to evaluate for causal effects 
and potential confounds.
An important limitation was the construction of the items meant to mea-
sure whether an RSME was triggered through the use of psychedelic sub-
stances or through other means. The first item allowed participants to indicate 
which substances that they had tried over the course of their life. The second 
item asked participants if that substance influenced their RSME. This struc-
ture allows for the possibility that we measured some RSMEs that were influ-
enced by other substances besides psychedelics, such as antidepressants, 
sedatives, opiates, psychiatric medications, antianxiety medications, and 
“party drugs.” Nonpsychedelic substances appear to exert a very small or 
nonexistent effect on mystical experience. While these substances have not 
been associated with RSMEs in the extant literature, further research differ-
entiating these substances is warranted.
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There were important differences between the two comparison groups, 
suggesting potential confounds. The psychedelic group had lower levels of 
education, lower SES, and a higher percentage of atheists and male respon-
dents than the nonpsychedelic group. In general, religious participants used 
psychedelics less often than did nonreligious participants. Additionally, reli-
gious individuals from monotheistic traditions tend to score lower on the 
mystical experience measure used in this study (Yaden et al., 2015). Finally, 
though we were able to control for gender, education, SES, and religious 
affiliation in the current analysis, future research should include these and 
other possible demographic covariates.
Implications
The findings of this study have implications for both research and application. 
The results add to the growing literature that suggests that further studies on 
psychedelic substances and their potential therapeutic value are merited. 
Future research should leverage interventional studies and randomized control 
trials to examine how religious, spiritual, and secular interpretations moderate 
the impact of psychedelically induced RSMEs on outcomes of interest.
These data provide evidence that the use of psychedelic substances is 
associated with RSMEs that are similar to, and may, on average, surpass in 
mystical quality RSMEs induced through other means. However, other trig-
gers of RSMEs should also receive additional empirical investigation. 
Meditation (Newberg & d’Aquili, 2000; Newberg et al., 2001), prayer 
(Newberg et al., 2015), rituals (Yaden, Iwry, Smith, & Pawelski, 2016), non-
invasive brain stimulation (Yaden, Anderson, Mattar, & Newberg, 2015; 
Yaden & Newberg, 2014), and other experiences involving intense awe 
(Yaden, Iwry, Slack, et al., 2016) may all provide feasible methods to facili-
tate further study.
In addition to the clinical applications already discussed, supervised psy-
chedelic sessions could be considered as a potential form of positive inter-
vention (Rashid, 2009; Seligman, Steen, Park, & Peterson, 2005) given their 
impact on dimensions of well-being (i.e., sense of purpose). While psyche-
delic experiences likely have therapeutic benefits for clinical populations, 
they could also be tested in some contexts for their capacity to increase well-
being beyond the treatment of specific pathologies.
Conclusion
The perceived authenticity and benefit of RSMEs induced through use of 
psychedelic substances—as opposed to experiences that occur through other 
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means—has long been a theoretical concern. Over a century ago, when 
William James addressed his audience at the Gifford lecture series that would 
become The Varieties of Religious Experience, many in attendance dismissed 
asceticism (such as techniques of fasting, retreats, or intense focus) as legiti-
mate religious practices. James went to some lengths to reverse this perspec-
tive, concluding his discussion with “you must be ready now to judge the 
religious life by its results exclusively, and I shall assume that the bugaboo of 
morbid origin will scandalize your piety no more” (James, 1902/1999, p. 25). 
Similarly, today, RSMEs occasioned by the use of psychedelic substances are 
dismissed by many as illegitimate—that is, the bugaboo of morbid origin 
continues to scandalize. The results of the preset study, however, suggest that 
psychedelic experiences can equal or even surpass the intensity and impact of 
experiences derived through nonpsychedelic means.
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